1. Belbasis L, Köhler C, Stefanis N, Stubbs B, Van Os J, Vieta E, et al. Risk factors and peripheral biomarkers for schizophrenia spectrum disorders: an umbrella review of meta‐analyses. Acta Psychiatr Scand. 2018; 137(2): 88-97. [DOI:10.1111/acps.12847] [PMID]

2. Association AP Diagnostic and statistical manual of mental disorders (DSM-5®): American Psychiatric Pub; 2013

3. Föcking M, Doyle B, Munawar N, Dillon ET, Cotter D, Cagney G. Epigenetic factors in schizophrenia: mechanisms and experimental approaches. Mol Neuropsychiatry. 2019; 5(1): 6-12. [DOI:10.1159/000495063] [PMID] []

4. Ding HA. Emerging concepts of specific components of the immune system in schizophrenia. Am J Psychiatry. 2018; 13(10): 2-4. [DOI:10.1176/appi.ajp-rj.2018.131001]

5. Dinan TG, Stilling RM, Stanton C, Cryan JF. Collective unconscious: how gut microbes shape human behavior. J Psychiatr Res. 2015; 63: 1-9. [DOI:10.1016/j.jpsychires.2015.02.021] [PMID]

6. Babakhani S, Hosseini F. Gut Microbiota: An Effective Factor in the Human Brain and Behavior. Shefaye Khatam. 2019; 7(1): 106-118. [DOI:10.29252/shefa.7.1.106]

7. Zhu X, Han Y, Du J, Liu R, Jin K, Yi WJO. Microbiota-gut-brain axis and the central nervous system. Oncotarget. 2017; 8(32): 53829-38. [DOI:10.18632/oncotarget.17754] [PMID] []

8. Lv F, Chen S, Wang L, Jiang R, Tian H, Li J, et al. The role of microbiota in the pathogenesis of schizophrenia and major depressive disorder and the possibility of targeting microbiota as a treatment option. Oncotarget. 2017; 8(59): 100899. [DOI:10.18632/oncotarget.21284] [PMID] []

9. Yatsunenko T, Rey FE, Manary MJ, Trehan I, Dominguez-Bello MG, Contreras M, et al. Human gut microbiome viewed across age and geography. Nature. 2012; 486(7402): 222-27. [DOI:10.1038/nature11053] [PMID] []

10. David LA, Materna AC, Friedman J, Campos-Baptista MI, Blackburn MC, Perrotta A, et al. Host lifestyle affects human microbiota on daily timescales. Genome Biol. 2014; 15(7): R89. [DOI:10.1186/gb-2014-15-7-r89] [PMID] []

11. Wu GD, Chen J, Hoffmann C, Bittinger K, Chen Y-Y, Keilbaugh SA, et al. Linking long-term dietary patterns with gut microbial enterotypes. Science. 2011; 334(6052): 105-108. [DOI:10.1126/science.1208344] [PMID] []

12. Evrensel A, Ceylan ME. Microbiome: the missing link in neuropsychiatric disorders. EMJ Innov. 2017; 1(1) 83-8. [DOI:10.33590/emjinnov/10313424]

13. Al-Asmakh M, Anuar F, Zadjali F, Rafter J, Pettersson SJGm. Gut microbial communities modulating brain development and function. Gut Microbes. 2012; 3(4): 366-73. [DOI:10.4161/gmic.21287] [PMID] []

14. Holmes E, Li JV, Marchesi JR, Nicholson JKJCm. Gut microbiota composition and activity in relation to host metabolic phenotype and disease risk. Cell Metab. 2012; 16(5): 559-64. [DOI:10.1016/j.cmet.2012.10.007] [PMID]

15. Tognini PJFicn. Gut microbiota: a potential regulator of neurodevelopment. Front Cell Neurosci. 2017; 11: 25. [DOI:10.3389/fncel.2017.00025] [PMID] []

16. Fond GB, Lagier J-C, Honore S, Lancon C, Korchia T, Verville P-LSD, et al. Microbiota-Orientated Treatments for Major Depression and Schizophrenia. Nutrients. 2020; 12(4): 1024. [DOI:10.3390/nu12041024] [PMID] []

17. Clarke G, Grenham S, Scully P, Fitzgerald P, Moloney R, Shanahan F, et al. The microbiome-gut-brain axis during early life regulates the hippocampal serotonergic system in a sex-dependent manner. Mol Psychiatry. 2013; 18(6): 666-73. [DOI:10.1038/mp.2012.77] [PMID]

18. Cryan JF, O'Riordan KJ, Cowan CS, Sandhu KV, Bastiaanssen TF, Boehme M, et al. The microbiota-gut-brain axis. Physiol Rev. 2019; 99(4): 1877-2013. [DOI:10.1152/physrev.00018.2018] [PMID]

19. Cryan JF, Dinan TG. Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour. Nature Rev Neurosci. 2012; 13(10): 701-12. [DOI:10.1038/nrn3346] [PMID]

20. Evrensel A, Ceylan EM. The Gut-Brain Axis: The missing link in depression. Clin Psychopharmacol Neurosci. 2015; 13(3): 239-48. [DOI:10.9758/cpn.2015.13.3.239] [PMID] []

21. Cussotto S, Sandhu KV, Dinan TG, Cryan JF. The neuroendocrinology of the microbiota-gut-brain axis: a behavioural perspective. Front Neuroendocrinol. 2018; 51: 80-101. [DOI:10.1016/j.yfrne.2018.04.002] [PMID]

22. Borre YE, Moloney RD, Clarke G, Dinan TG, Crayan JF. The impact of microbiota on brain and behavior: mechanisms & therapeutic potential. Adv Exp Med Biol. 2014; 817: 373-403. [DOI:10.1007/978-1-4939-0897-4_17] [PMID]

23. Foster JA, Rinaman L, Cryan JFJNos. Stress & the gut-brain axis: regulation by the microbiome. Neurobiol Stress. 2017; 7: 124-36. [DOI:10.1016/j.ynstr.2017.03.001] [PMID] []

24. Carabotti M, Scirocco A, Maselli MA, Severi C. The gut-brain axis: interactions between enteric microbiota, central and enteric nervous systems. Ann Gastroenterol. 2015; 28(2): 203-209.

25. Mayer EA, Knight R, Mazmanian SK, Cryan JF, Tillisch K. Gut microbes and the brain: paradigm shift in neuroscience. J Neurosci. 2014; 34(46): 15490-6. [DOI:10.1523/JNEUROSCI.3299-14.2014] [PMID] []

26. Rea K, Dinan TG, Cryan JF. The microbiome: a key regulator of stress and neuroinflammation. Neurobiol Stress. 2016; 4: 23-33. [DOI:10.1016/j.ynstr.2016.03.001] [PMID] []

27. Sandhu KV, Sherwin E, Schellekens H, Stanton C, Dinan TG, Cryan JF. Feeding the microbiota-gut-brain axis: diet, microbiome, and neuropsychiatry. Trans Res. 2017; 179: 223-44. [DOI:10.1016/j.trsl.2016.10.002] [PMID]

28. Severance EG, Yolken RH, Eaton WW. Autoimmune diseases, gastrointestinal disorders and the microbiome in schizophrenia: more than a gut feeling. Schizophr Res. 2016; 176(1): 23-35. [DOI:10.1016/j.schres.2014.06.027] [PMID] []

29. Yuan X, Kang Y, Zhuo C, Huang X-F, Song X. The gut microbiota promotes the pathogenesis of schizophrenia via multiple pathways. Biochem Biophys Res Comun. 2019; 512(2): 373-80. [DOI:10.1016/j.bbrc.2019.02.152] [PMID]

30. Genedi M JI, Haarman BBCM, Sommer IEC. Dysregulation of the gut-brain axis in schizophrenia and bipolar disorder: probiotic supplementation as a supportive treatment in psychiatric disorders. Curr Opin Psychiatry. 2019; 32(3): 185-95. [DOI:10.1097/YCO.0000000000000499] [PMID]

31. R Caso J, Balanza-Martinez V, Palomo T, Garcia-Bueno B. The microbiota and gut-brain axis: contributions to the immunopathogenesis of schizophrenia. Curr Pharmaceut Design. 2016; 22(40): 6122-33. [DOI:10.2174/1381612822666160906160911] [PMID]

32. Xu M-Q, Cao H-L, Wang W-Q, Wang S, Cao X-C, Yan F, et al. Fecal microbiota transplantation broadening its application beyond intestinal disorders. World J Gastroenterol. 2015; 21(1): 102-111. [DOI:10.3748/wjg.v21.i1.102] [PMID] []

33. Evrensel A, Ceylan EM. Neuroscience. Fecal microbiota transplantation and its usage in neuropsychiatric disorders. Clin Psychopharmacol Neurosci. 2016; 14(3): 231-37. [DOI:10.9758/cpn.2016.14.3.231] [PMID] []

34. Zhu F, Guo R, Wang W, Ju Y, Wang Q, Ma Q, et al. Transplantation of microbiota from drug-free patients with schizophrenia causes schizophrenia-like abnormal behaviors and dysregulated kynurenine metabolism in mice. Mol Psychiatry. 2020; 25: 2905-18. [DOI:10.1038/s41380-019-0475-4] [PMID]

35. Wang S, Xu M, Wang W, Cao X, Piao M, Khan S, et al. Systematic review: adverse events of fecal microbiota transplantation. PloS one. 2016 ;11(8): e0161174. [DOI:10.1371/journal.pone.0161174] [PMID] []

36. Aryan E, Makvandi M, Farajzadeh A, Huygen K, Alvandi AH, Gouya MM, Sadrizadeh A, Romano M. Clinical value of IS6110-based loop-mediated isothermal amplification for detection of Mycobacterium tuberculosis complex in respiratory specimens. J Infect. 2013; 66(6): 487-93. [DOI:10.1016/j.jinf.2013.02.005] [PMID]

37. Aryan E, Makvandi M, Farajzadeh A, Huygen K, Bifani P, Mousavi SL, Fateh A, Jelodar A, Gouya MM, Romano M. A novel and more sensitive loop-mediated isothermal amplification assay targeting IS6110 for detection of Mycobacterium tuberculosis complex. Microbiol Res. 2010; 165(3): 211-20. [DOI:10.1016/j.micres.2009.05.001] [PMID]

38. Salimiyan Rizi K, Aryan E, Meshkat Z, Ranjbar G, Sankian M, Ghazvini K, Farsiani H, Pourianfar HR, Rezayi M. The overview and perspectives of biosensors and Mycobacterium tuberculosis: A systematic review. J Cell Physiol. 2021; 236(3): 1730-1750. [DOI:10.1002/jcp.30007] [PMID]

39. Rizi KS, Hatamluyi B, Rezayi M, Meshkat Z, Sankian M, Ghazvini K, Farsiani H, Aryan E. Response surface methodology optimized electrochemical DNA biosensor based on HAPNPTs/PPY/MWCNTs nanocomposite for detecting Mycobacterium tuberculosis. Talanta. 2021; 226: 122099. [DOI:10.1016/j.talanta.2021.122099] [PMID]